NCT06153017

Brief Summary

Reliable prediction of upper limb (UL) function can guide clinicians in choosing relevant treatment, helps to set realistic goals for rehabilitation and will contribute to personalized and effective rehabilitation. TMS has been identified as a strong predictor of future UL function after stroke. With this project, the investigators want to implement the standard use of TMS examination for a defined patient group in the clinical setting and systematically evaluate the implementation process. The impact and perceived value of TMS in the clinical setting will be evaluated and the predictive value of TMS for the specific patient population will be assessed.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 14, 2023

Completed
6 months until next milestone

First Posted

Study publicly available on registry

December 1, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

2.7 years

First QC Date

June 14, 2023

Last Update Submit

May 17, 2025

Conditions

Keywords

Transcranial Magnetic StimulationUpper limb functionStrokeNeurorehabilitationImplementationBiomarker

Outcome Measures

Primary Outcomes (1)

  • Action Research Arm Test

    Assesses arm motor function, range 0-57 (best)

    3 months after stroke

Secondary Outcomes (2)

  • Shoulder Abduction Finger Extension Test

    3 months after stroke

  • Fugl-Meyer Motor Assessment Upper Limb (0-66 best)

    3 months after stroke

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We include patients with stroke and severe paresis or paralysis of an upper limb after stroke.

You may qualify if:

  • admitted to rehabilitation within 21 days after stroke
  • severe UL impairment, either paralysis (no active movement), or severe paresis, defined as Fugl-Meyer Assessment \<17 or Shoulder Abduction Finger Extension (SAFE) score \< 5
  • At least 18 years old
  • able to provide informed consent and comply with examination procedures

You may not qualify if:

  • Epilepsy
  • Metal implants in the head
  • Other implanted electronics (cardiac pacemaker, defibrillator, cochlear implant, medication pump)
  • Skull fracture or serious head injury
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hammel Neurorehabilitation Centre and University Research Clinic

Hammel, Aarhus, 8450, Denmark

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, associate professor

Study Record Dates

First Submitted

June 14, 2023

First Posted

December 1, 2023

Study Start

May 1, 2023

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 21, 2025

Record last verified: 2025-05

Locations